Brexit Could Make UK A 'Second-Tier State' For Innovative New Drugs, Business Committee Warns

 
• By Ian Schofield
  
EU_UK
A UK parliamentary committee has outlined the drawbacks of Brexit for the pharma sector

More from Approvals

More from Product Reviews